Live from the NIH registry
Studies recruiting near Los Angeles right now
Top 25 of 2,945 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (10.3 mi)
· Sponsor: University of Pennsylvania
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) — Los Angeles, California (10.3 mi)
· Sponsor: Pierre Fabre Medicament
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma
Phase 1
Interventional 46 participants sought
University of Southern California — Los Angeles, California (10.3 mi)
· Sponsor: SciTech Development, Inc.
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Prostate Carcinoma
N/A
Observational 300 participants sought
Los Angeles General Medical Center — Los Angeles, California (10.3 mi)
· Sponsor: University of Southern California
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (10.3 mi)
· Sponsor: Pacific Edge Limited
Access to Genetic Testing in Underserved Patients With Cancer
Breast Carcinoma, Male Breast Carcinoma
N/A
Interventional 800 participants sought
USC / Norris Comprehensive Cancer Center — Los Angeles, California (10.3 mi)
· Sponsor: University of Southern California
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (10.3 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (10.3 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (2.8 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
UCLA Clinical & Translational Research Center (CTRC) — Los Angeles, California (10.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (24.6 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina-Vitreous Associates Medical Group — Beverly Hills, California (2.8 mi)
· Sponsor: Boehringer Ingelheim
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (8.9 mi)
· Sponsor: IceCure Medical Ltd.
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University of Southern California-Children's Hospital — Los Angeles, California (10.3 mi)
· Sponsor: University of Michigan
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (24.6 mi)
· Sponsor: City of Hope Medical Center
Regional Blocks for Lateral Condyle Fractures
Fractures, Closed, Humeral Fractures
Phase 4
Interventional 90 participants sought
Orthopaedic Institute for Children — Los Angeles, California (10.3 mi)
· Sponsor: University of California, Los Angeles
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (15.2 mi)
· Sponsor: Genentech, Inc.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Eye Physicians of Long Beach — Long Beach, California (27.0 mi)
· Sponsor: VisionCare, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (10.3 mi)
· Sponsor: National Cancer Institute (NCI)
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Metastatic Castration-resistant Prostate Cancer
Phase 1
Interventional 50 participants sought
City of Hope Medical Center — Duarte, California (24.6 mi)
· Sponsor: Full-Life Technologies UK Limited
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California (27.0 mi)
· Sponsor: VA Office of Research and Development
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease
Phase 1, Phase 2
Interventional 54 participants sought
UCLA TMS Clinical and Research Service — Los Angeles, California (10.3 mi)
· Sponsor: University of California, Los Angeles
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (10.3 mi)
· Sponsor: AbbVie
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Disney Family Cancer Center — Burbank, California (7.2 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Keck Medical Center of USC — Los Angeles, California (10.3 mi)
· Sponsor: Jaeb Center for Health Research